Search research articles
Contact Us
Filters
Showing results (431-440 of 1,746) with videos related to
Page
of 175
Sort By:
Applied Microbiology and Biotechnology
|
January 10, 2002
Cell surface-engineered yeast displaying a histidine oligopeptide (hexa-His) has enhanced adsorption of and tolerance to heavy metal ions
K Kuroda, S Shibasaki, M Ueda, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
December 7, 2000
[Transitional cell carcinoma of urachus: a case report]
K Abe, T Wada, M Ueda, et al.
Anesthesiology
|
October 19, 2001
Role of potassium channels in isoflurane- and sevoflurane-induced attenuation of hypoxic pulmonary vasoconstriction in isolated perfused rabbit lungs
R Liu, M Ueda, N Okazaki, et al.
Japanese Circulation Journal
|
July 1, 1975
[Proceedings: Latent cases of conduction disturbances]
K Sugiki, M Ueda, K Yoshino, et al.
Journal of Surgical Oncology
|
November 23, 2000
Modified stomach roll for safer reconstruction after subtotal esophagectomy
T Matsubara, M Ueda, C Uchida, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
|
February 24, 2001
Interface analysis of titanium implants in a human vascularized fibula bone graft
Y Sumi, T Hasegawa, O Miyaishi, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen
M Igawa, H Kadena, M Ueda, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
September 1, 1994
M-VEC (methotrexate, vinblastine, 4'-epirubicin and cisplatin) combined with glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the treatment of transitional cell carcinoma of urothelium: reduction in toxicity produced by rhG-CSF
M Ueda, M Igawa, H Kadena, et al.
Journal of Medicine
|
January 1, 1995
Clinicopathological features of well-differentiated cervical adenocarcinoma with abundant mucus secretion
M Ueki, M Ueda, S Okamura, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
|
January 1, 1993
Temporal necrotizing infection of dental origin
I Mizuno, H Mizutani, M Ueda, et al.
Page
of 175
Search research articles
Search
Showing results (431-440 of 1,746) with videos related to
Sort By:
Page
of 175
Applied Microbiology and Biotechnology
|
January 10, 2002
Cell surface-engineered yeast displaying a histidine oligopeptide (hexa-His) has enhanced adsorption of and tolerance to heavy metal ions
K Kuroda, S Shibasaki, M Ueda, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
December 7, 2000
[Transitional cell carcinoma of urachus: a case report]
K Abe, T Wada, M Ueda, et al.
Anesthesiology
|
October 19, 2001
Role of potassium channels in isoflurane- and sevoflurane-induced attenuation of hypoxic pulmonary vasoconstriction in isolated perfused rabbit lungs
R Liu, M Ueda, N Okazaki, et al.
Japanese Circulation Journal
|
July 1, 1975
[Proceedings: Latent cases of conduction disturbances]
K Sugiki, M Ueda, K Yoshino, et al.
Journal of Surgical Oncology
|
November 23, 2000
Modified stomach roll for safer reconstruction after subtotal esophagectomy
T Matsubara, M Ueda, C Uchida, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
|
February 24, 2001
Interface analysis of titanium implants in a human vascularized fibula bone graft
Y Sumi, T Hasegawa, O Miyaishi, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen
M Igawa, H Kadena, M Ueda, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
September 1, 1994
M-VEC (methotrexate, vinblastine, 4'-epirubicin and cisplatin) combined with glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the treatment of transitional cell carcinoma of urothelium: reduction in toxicity produced by rhG-CSF
M Ueda, M Igawa, H Kadena, et al.
Journal of Medicine
|
January 1, 1995
Clinicopathological features of well-differentiated cervical adenocarcinoma with abundant mucus secretion
M Ueki, M Ueda, S Okamura, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
|
January 1, 1993
Temporal necrotizing infection of dental origin
I Mizuno, H Mizutani, M Ueda, et al.
Page
of 175